SCHEMBL17829161

SCHEMBL17829161

Fc1cccc(-c2cccc(-c3nc(-c4cc(-n5c6ccccc6c6ccc(-n7c8ccccc8c8ccccc87)cc65)cc(-n5c6ccccc6c6ccc(-n7c8ccccc8c8ccccc87)cc65)c4)c4c(ccc5ccccc54)n3)c2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.33
ALDH1A1 P00352 2/20 0.32
HTT P42858 2/20 0.32
KDM4E B2RXH2 1/20 0.32
XBP1 P17861 1/20 0.32
MAPK1 P28482 1/20 0.32
ADORA2A P29274 1/20 0.32
MAPT P10636 2/20 0.32
CYP1A2 P05177 3/20 0.32
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
PRKDC P78527 1/20 0.32
NT5E P21589 2/20 0.31
DPP4 P27487 1/20 0.31
USP2 O75604 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829180 0.90 PTGES (0.35) ABCG2ADORA2AMAPTCYP1A2NT5E
SCHEMBL17829143 0.90 PTGES (0.35) ABCG2KDM4EADORA2ACYP1A2NT5E
SCHEMBL17829164 0.89 PTGES (0.36) ABCG2KDM4EADORA2ACYP1A2NT5E
SCHEMBL17829197 0.86 ABCG2 (0.35) ABCG2ALDH1A1HTTKDM4EXBP1
SCHEMBL17829168 0.86 NT5E (0.36) ABCG2ADORA2ACYP1A2NT5EDPP4
SCHEMBL17829183 0.84 FLT3 (0.32) ALDH1A1HTTKDM4EXBP1MAPT
SCHEMBL17831773 0.84 ABCG2 (0.32) ABCG2ALDH1A1HTTMAPTDPP4
SCHEMBL17829039 0.83 PTGES (0.37) ALDH1A1HTTKDM4EMAPTNPC1
SCHEMBL17828910 0.82 KDM4E (0.38) ABCG2ALDH1A1HTTKDM4EMAPT
SCHEMBL17829018 0.82 PTGES (0.39) ABCG2ALDH1A1HTTKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 ABCG2 4502/4885ALDH1A1 248/4885HTT 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.